Nexgel (NXGLW) Return on Capital Employed (2019 - 2025)
Nexgel's (NXGLW) quarterly Return on Capital Employed came in at 41.46% in Q4 2025, up 132.0% YoY from 17.87% in Q4 2024, and down 2.4% on a QoQ basis from 40.49% in Q3 2025.
Nexgel (NXGLW) Return on Capital Employed (2019 - 2025) Analysis & Trends
Nexgel (NXGLW) has 7 years of Return on Capital Employed data on file, last reported at 41.46% in Q4 2025.
- Quarterly Return on Capital Employed rose 132.0% year-over-year to 41.46% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 41.46% (up 132.0% YoY) and the FY2025 annual result came in at 43.16%, up 127.0% from the prior year.
- Return on Capital Employed fell to 41.46% in Q4 2025, from 40.49% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 20.85% in Q1 2022 to a low of 183.22% in Q1 2021.
- A 5-year average of 53.36% and a median of 40.98% in 2025 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 21970 bps in 2021, down 7050 bps in 2021.
- Tracing NXGLW's Return on Capital Employed over 5 years: stood at 31.83% in 2021, then fell by 6 bps to 33.69% in 2022, then sank by 39 bps to 46.96% in 2023, then gained by 9 bps to 42.78% in 2024, then grew by 3 bps to 41.46% in 2025.
- The last three Return on Capital Employed figures came in at 41.46% (Q4 2025), 40.49% (Q3 2025), and 39.62% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | -126.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.46% |
| Sep 30, 2025 | -40.49% |
| Jun 30, 2025 | -39.62% |
| Mar 31, 2025 | -42.24% |
| Dec 31, 2024 | -42.78% |
| Sep 30, 2024 | -55.18% |
| Jun 30, 2024 | -50.43% |
| Mar 31, 2024 | -45.06% |
| Dec 31, 2023 | -46.96% |
| Sep 30, 2023 | -35.41% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | -37.33% |
| Dec 31, 2022 | -33.69% |
| Sep 30, 2022 | -30.33% |
| Jun 30, 2022 | -26.47% |
| Mar 31, 2022 | -20.85% |
| Dec 31, 2021 | -31.83% |
| Sep 30, 2021 | -111.46% |
| Jun 30, 2021 | -114.31% |
| Mar 31, 2021 | -183.22% |